Tags

Type your tag names separated by a space and hit enter

Treatment of alopecia areata with topical sensitizers.
Dermatitis. 2015 Jan-Feb; 26(1):26-31.D

Abstract

For those with severe alopecia areata, with greater than 50% scalp involvement, topical immunotherapy with diphenylcyclopropenone or squaric acid dibutylester is considered the treatment of choice. This article not only reviews the safety and efficacy of topical sensitizers for the treatment of alopecia areata but also highlights strides that have been made in the literature concerning their use in pediatric populations, molecular mechanisms of efficacy, and improved safety through targeted delivery methods.

Links

Publisher Full Text (DOI)

Authors+Show Affiliations

Sutherland L
From the Department of Dermatology, University of Maryland School of Medicine, Baltimore.
Laschinger M
No affiliation info available
Syed ZU
No affiliation info available
Gaspari A
No affiliation info available

MeSH

Adjuvants, ImmunologicAdministration, CutaneousAlopecia AreataCyclobutanesCyclopropanesHumans

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

25581667

Citation

Sutherland, Lesley, et al. "Treatment of Alopecia Areata With Topical Sensitizers." Dermatitis : Contact, Atopic, Occupational, Drug, vol. 26, no. 1, 2015, pp. 26-31.
Sutherland L, Laschinger M, Syed ZU, et al. Treatment of alopecia areata with topical sensitizers. Dermatitis. 2015;26(1):26-31.
Sutherland, L., Laschinger, M., Syed, Z. U., & Gaspari, A. (2015). Treatment of alopecia areata with topical sensitizers. Dermatitis : Contact, Atopic, Occupational, Drug, 26(1), 26-31. https://doi.org/10.1097/DER.0000000000000094
Sutherland L, et al. Treatment of Alopecia Areata With Topical Sensitizers. Dermatitis. 2015 Jan-Feb;26(1):26-31. PubMed PMID: 25581667.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Treatment of alopecia areata with topical sensitizers. AU - Sutherland,Lesley, AU - Laschinger,Mary, AU - Syed,Zain U, AU - Gaspari,Anthony, PY - 2015/1/13/entrez PY - 2015/1/13/pubmed PY - 2015/9/16/medline SP - 26 EP - 31 JF - Dermatitis : contact, atopic, occupational, drug JO - Dermatitis VL - 26 IS - 1 N2 - For those with severe alopecia areata, with greater than 50% scalp involvement, topical immunotherapy with diphenylcyclopropenone or squaric acid dibutylester is considered the treatment of choice. This article not only reviews the safety and efficacy of topical sensitizers for the treatment of alopecia areata but also highlights strides that have been made in the literature concerning their use in pediatric populations, molecular mechanisms of efficacy, and improved safety through targeted delivery methods. SN - 2162-5220 UR - https://www.unboundmedicine.com/medline/citation/25581667/Treatment_of_alopecia_areata_with_topical_sensitizers_ DB - PRIME DP - Unbound Medicine ER -